Addressing stakeholders' needs: economics and XXXX satisfaction.

@entity1 @entity1337 @entity158
PURPOSE: The economics of acute post-operative @entity158 management are discussed. Studies identifying cost drivers in post-operative @entity158 treatment and the economic sequelae of undertreated @entity158 are reviewed. The relative costs of intermittent intramuscular @entity1337 , intravenous @entity1 -controlled @entity1337 , and epidural @entity1337 are described. Medication errors and their consequences are addressed. The importance of @entity1 satisfaction and data on its correlation with acute post-operative @entity158 are reviewed. SUMMARY: Although the economics of acute post-operative @entity158 treatment are difficult to accurately assess, studies have demonstrated that pharmacy acquisition costs represent as little as 1% of the total hospital cost of surgical treatment. Costs of @entity1337 are driven largely by staff time. Inadequate treatment of post-operative @entity158 can have important economic ramifications associated with increased @entity1 morbidity, extended hospital stays, and readmissions. Inadequate treatment of post-operative @entity158 is also associated with reduced @entity1 satisfaction, a measure of increasing importance to health systems and pharmacists who practice within them. CONCLUSION: Undertreatment of acute post-operative @entity158 has important implications for health systems from the standpoints of economics and @entity1 satisfaction.
